Diseases, Conditions, Syndromes

Recommendations updated for idiopathic pulmonary fibrosis

In a clinical practice guideline issued by the American Thoracic Society, together with the European Respiratory Society, Japanese Respiratory Society, and Asociacion Latinoamericana de Torax, updated recommendations are ...

Medical research

Damaged lungs breathe life into COVID research

A small black lump, about an inch or so in width, rests on the bottom of a sealed plastic container. It doesn't look like much—in fact, it doesn't look like anything. But this little black lump has untold potential, full ...

Diseases, Conditions, Syndromes

Research suggests new way to detect, monitor lung diseases

New lung research from an international team of scientists could offer doctors a new way to detect and monitor progressive lung diseases—and may also shed light on the fundamental causes of those conditions.


RNA therapy for heart failure and organ fibrosis

RNA has already been making an impact in the context of the vaccine program, but the potential of RNA-based compounds is far from being fully tapped, as RNA allows for entirely new therapeutic approaches. Prof. Thomas Thum, ...

page 1 from 26

Interstitial lung disease

Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs). It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues.

The term ILD is used to distinguish these diseases from obstructive airways diseases.

Most types of ILD involve fibrosis, but this is not essential. The term "pulmonary fibrosis" is no longer considered a synonym. Idiopathic pulmonary fibrosis is one form of "interstitial lung disease".

This text uses material from Wikipedia, licensed under CC BY-SA